A polyp is an abnormal growth of tissue projecting from a mucous membrane commonly
found in the colon, stomach, nose, ear, sinus, urinary bladder, uterus etc. although they
may occur elsewhere in the body where mucous membranes exist. Most polyps are benign
or non-cancerous while a few are premalignant. Premalignant polyps can be a trigger
factors for cancer and in general, the larger the polyp, the greater the risk of cancer,
especially with pre-malignant polyps. Most polyps have no symptoms and screening is the
only reliable measure to detect them. Symptoms, when evident, are irregular periods and
vaginal bleeding in women, dysmenorrhea, pain, diarrhoea, constipation, nausea, vomiting
etc. depending on the location of the polyp.
The Global Polyps Market is expected to reach US$ 18.3 billion by 2023, and the market is
projected to grow at a CAGR of ~ 9.2 % during the forecast period 2017-2023.
Screening is the most important driver for the global polyp market. Polyp are the most
important risk factors for colon cancer and most colorectal cancers begin as a polyp, a
growth in the tissue that lines the inner surface of the colon or rectum. A certain type of
polyp known as an adenoma may have a higher risk of becoming a cancer and colorectal
cancer is the third most common type of non-skin cancer in both men and women and is the
second leading cause of cancer death in the United States after lung cancer. The U.S.
Department of Health and Human Services estimates that in 2016, an estimated 134,490
people in the United States were diagnosed with colorectal cancer and 49,190 people died
from contracting it.
The market drivers for polyp market are increasing geriatric population, growing screening,
rising awareness and their potentially cancerous nature. The market restraints are risks
such as bleeding and infection during surgery, low healthcare expenditure in developing
regions, costs considerations especially for minimally invasive surgeries, no symptoms of
most polyps, personal or family history of polyps etc.
Segments:
The global Polyps Market has been segmented on the basis of stage, types, diagnosis,
surgery and end users.
Based on stage, the market has been segmented as benign and pre-malignant.
Based on types, the market has been segmented as digestive polyps, endometrial polyp,
cervical polyp, nasal polyps, laryngeal polyps and pre-malignant.
Based on diagnosis, the market has been segmented as occult blood and stool test,
colonoscopy, sigmoidoscopy, double contrast barium enema, computed tomography and
others.
Based on treatment, the market has been segmented as drugs which is further sub
segmented into hormonal drugs, pain killers and others and surgery which is further sub
segmented into polypectomy, minimally invasive surgery, colon and rectum removal and
others.
Based on the end users, the market has been segmented as hospitals & clinics, academic
and research and others.
Key Players in the Global Polyps Market
Some of key players profiled in the report are Millennium Surgical Corp., Black Smith
Surgical, B. Braun Melsungen AG, Medtronic, Cook Medical, Endo Pharmaceuticals Inc.,
Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan Inc., Sun
Pharmaceuticals and others.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4176 .
Regional analysis:
The Americas account for a significant market share owing to extensive use of medications
and high expenditure on the health care. Additionally, the fastest uptake of new technology
in the US drives the global polyps market. Also, concentration of major research companies
and cancer research sector in the developed countries of this region is adding fuel to the
market growth.